Skip to the page

Data / Form D filings / Rasio Therapeutics, Inc.

Rasio Therapeutics, Inc.: Form D filing

Rasio Therapeutics, Inc., a biotechnology company in Baltimore, MD, filed a Form D with the SEC in 2021. The latest, on November 26, 2021, reports $1.5 million sold of a $1.5 million offering to 2 investors.

Find out what Rasio Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1100 WICOMICO STREET, SUITE 323, Baltimore, MD, 21230
Phone
(601) 818-0612
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1895690

The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 26, 2021New notice$1,500,000$1,500,000$02Nov 12, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Raju KucherlapatiDirector
Sujuan BaDirector
Ken MaloneExecutive Officer, Director

Other biotechnology companies in Maryland that filed recently

Every Form D from the week of Nov 22, 2021 · All recent filings in Maryland · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Rasio Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.